These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7961338)

  • 1. Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study.
    Black B; Uhde TW
    J Am Acad Child Adolesc Psychiatry; 1994 Sep; 33(7):1000-6. PubMed ID: 7961338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.
    Tollefson GD; Birkett M; Koran L; Genduso L
    J Clin Psychiatry; 1994 Oct; 55 Suppl():69-76; discussion 77-8. PubMed ID: 7961535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
    J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine for childhood anxiety disorders.
    Birmaher B; Waterman GS; Ryan N; Cully M; Balach L; Ingram J; Brodsky M
    J Am Acad Child Adolesc Psychiatry; 1994 Sep; 33(7):993-9. PubMed ID: 7961355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
    Nemeroff CB; Thase ME;
    J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.
    King BH; Wright DM; Handen BL; Sikich L; Zimmerman AW; McMahon W; Cantwell E; Davanzo PA; Dourish CT; Dykens EM; Hooper SR; Jaselskis CA; Leventhal BL; Levitt J; Lord C; Lubetsky MJ; Myers SM; Ozonoff S; Shah BG; Snape M; Shernoff EW; Williamson K; Cook EH
    J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):658-65. PubMed ID: 11392343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism.
    Fankhauser MP; Karumanchi VC; German ML; Yates A; Karumanchi SD
    J Clin Psychiatry; 1992 Mar; 53(3):77-82. PubMed ID: 1548248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group.
    Arch Gen Psychiatry; 1992 Feb; 49(2):139-47. PubMed ID: 1550466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind placebo controlled trial of fluoxetine in fibromyalgia.
    Wolfe F; Cathey MA; Hawley DJ
    Scand J Rheumatol; 1994; 23(5):255-9. PubMed ID: 7973479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine in posttraumatic stress disorder.
    van der Kolk BA; Dreyfuss D; Michaels M; Shera D; Berkowitz R; Fisler R; Saxe G
    J Clin Psychiatry; 1994 Dec; 55(12):517-22. PubMed ID: 7814344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder.
    Silver AA; Shytle RD; Sheehan KH; Sheehan DV; Ramos A; Sanberg PR
    J Am Acad Child Adolesc Psychiatry; 2001 Sep; 40(9):1103-10. PubMed ID: 11556635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine in the treatment of late luteal phase dysphoric disorder.
    Stone AB; Pearlstein TB; Brown WA
    J Clin Psychiatry; 1991 Jul; 52(7):290-3. PubMed ID: 2071558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine in the treatment of premenstrual syndrome.
    Stone AB; Pearlstein TB; Brown WA
    Psychopharmacol Bull; 1990; 26(3):331-5. PubMed ID: 2274633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine versus trazodone: efficacy and activating-sedating effects.
    Beasley CM; Dornseif BE; Pultz JA; Bosomworth JC; Sayler ME
    J Clin Psychiatry; 1991 Jul; 52(7):294-9. PubMed ID: 2071559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine for (s)elective mutism.
    Motavalli N
    J Am Acad Child Adolesc Psychiatry; 1995 Jun; 34(6):701-3. PubMed ID: 7608040
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
    Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine efficacy in social phobia.
    Van Ameringen M; Mancini C; Streiner DL
    J Clin Psychiatry; 1993 Jan; 54(1):27-32. PubMed ID: 8428894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric characteristics of children with selective mutism: a pilot study.
    Black B; Uhde TW
    J Am Acad Child Adolesc Psychiatry; 1995 Jul; 34(7):847-56. PubMed ID: 7649954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.